CIK 0001374690
- Non-accelerated filer
- Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203857670
- Phone
- +1 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- Open-market buys, last 90 days
- $402,143
- in 9 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$402,143. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-12 | Daniel Thomas O Director | Grant or award · Stock Option (right to buy) | +8,300 | 8,300 | ||
| 2020-09-29 | Daniel Thomas O Director | Grant or award · Stock Option (right to buy) | +16,600 | 16,600 | ||
| 2019-06-26 | Daniel Thomas O Director | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2019-01-24 | Daniel Thomas O Director | Grant or award · Stock Option (Right to Buy) | +13,280 | 13,280 | ||
| 2018-06-06 | Daniel Thomas O Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2018-01-03 | Daniel Thomas O Director | Grant or award | +8,687 | $5.18 | $45K | 19,452 |
| 2017-06-21 | Daniel Thomas O Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2017-02-13 | Daniel Thomas O Director | Grant or award | +10,765 | $4.18 | $45K | 10,765 |
| 2016-06-30 | Daniel Thomas O Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2016-04-01 | Daniel Thomas O Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2016-04-01 | Daniel Thomas O Director | Grant or award · Stock Option (Right to Buy) | +3,841 | 3,841 |
Page 1 of 1 · 11 trades